Newsroom

Press Releases

Saniona Icon blue
September 15, 2021
PRESS RELEASE 15 September 202 1 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the appointment of Wendy Dwyer as Chief Business Officer. Dwyer has more than 20 years of experience in business development , licensing, and mergers and
August 26, 2021
PRESS RELEASE August 26 , 202 1 Three Months Ended June 30, 2021 (2020) Revenue was SEK 1.9 M (2.0 M) Operating loss was SEK -103.6 M (-26.0 M) Net profit/loss was SEK -103.9 M (-23.9 M) Basic loss per share was SEK -1.67 (-0.81) Diluted loss per share was SEK -1.67 (-0.81) Six Months Ended June
June 30, 2021
PRESS RELEASE June 30 , 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that it has dosed the first patient in a P hase 1 clinical trial of SAN711, a novel molecule derived from Saniona’s proprietary ion channel drug discovery engine.
Displaying 1 - 10 of 38